| Kewaunee Health Services | |
| 1308 Lincoln St, Kewaunee, Wisconsin 54216 | |
| (920) 388-4111 | |
| Name | Kewaunee Health Services |
|---|---|
| Location | 1308 Lincoln St, Kewaunee, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 50 |
| Occupancy Rate | 51.6% |
| Medicare ID (CCN) | 525357 |
| Legal Business Name | Nsh Kewaunee Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1255974176 |
| Organization Name | NSH KEWAUNEE LLC |
| Address | 1308 Lincoln St, Kewaunee, WI 54216 |
| Phone Number | 920-388-3955 |
News Archive
The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.
Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
The Fiscal Times reports that the study by Bankrate.com shows government outreach efforts are falling short. Meanwhile, news outlets look at enrollment efforts in New Jersey, Montana, Maine, Washington, Pennsylvania, Ohio and California.
› Verified 7 days ago
| NPI Number | 1588657704 |
| Organization Name | KEWAUNEE CARE CENTER LLC |
| Doing Business As | D/B/A ATRIUM POST ACUTE CARE OF KEWAUNEE |
| Address | 1308 Lincoln St, Kewaunee, WI 54216 |
| Phone Number | 920-388-4111 |
News Archive
The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.
Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
The Fiscal Times reports that the study by Bankrate.com shows government outreach efforts are falling short. Meanwhile, news outlets look at enrollment efforts in New Jersey, Montana, Maine, Washington, Pennsylvania, Ohio and California.
› Verified 7 days ago
| NPI Number | 1801006580 |
| Organization Name | GREENFIELD REHAB AGENCY UNC. |
| Address | 1308 Lincoln St, Kewaunee, WI 54216 |
| Phone Number | 920-388-4111 |
News Archive
The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.
Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
The Fiscal Times reports that the study by Bankrate.com shows government outreach efforts are falling short. Meanwhile, news outlets look at enrollment efforts in New Jersey, Montana, Maine, Washington, Pennsylvania, Ohio and California.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.
Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
The Fiscal Times reports that the study by Bankrate.com shows government outreach efforts are falling short. Meanwhile, news outlets look at enrollment efforts in New Jersey, Montana, Maine, Washington, Pennsylvania, Ohio and California.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 15.63 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 61.54 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.8 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8.24 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.47 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.41 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.1 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.75 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 24.49 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 28.77 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 3.64 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.55 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.6 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.71 | 82.93 |
News Archive
The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.
Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.
Serametrix Corporation has announced the launch of an important new blood test for cancer patients. The test measures a patient's level of circulating Myeloid Derived Suppressor Cells (MDSCs) that are known to decrease anti-tumor immunity and are associated with poor survival rates in cancer patients.
The Fiscal Times reports that the study by Bankrate.com shows government outreach efforts are falling short. Meanwhile, news outlets look at enrollment efforts in New Jersey, Montana, Maine, Washington, Pennsylvania, Ohio and California.
› Verified 7 days ago